BCL-2 Family Proteins as Therapeutic Targets in Multiple Myeloma - Episode 7

Venetoclax in Combination with Carfilzomib for Multiple Myeloma Treatment

,

Sponsored in Part by AbbVie/Content Independently Developed by Targeted Oncology. Oncologists discuss the use of carfilzomib for multiple myeloma and their typical treatment regimens of choice.